首页 > 最新文献

British Journal of Surgery最新文献

英文 中文
Application of the associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) technique in conversion therapy for hepatocellular carcinoma. 联合肝分区门静脉结扎分期肝切除术(ALPPS)技术在肝癌转化治疗中的应用。
IF 8.6 1区 医学 Q1 SURGERY Pub Date : 2025-03-28 DOI: 10.1093/bjs/znaf067
Jingyun Ning, Cao Dai, Qin Liu, Haoming Lin, Rui Zhang
{"title":"Application of the associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) technique in conversion therapy for hepatocellular carcinoma.","authors":"Jingyun Ning, Cao Dai, Qin Liu, Haoming Lin, Rui Zhang","doi":"10.1093/bjs/znaf067","DOIUrl":"https://doi.org/10.1093/bjs/znaf067","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"112 4","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143951629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a patient-reported outcome measure for gastrointestinal recovery after surgery (PRO-diGI). 患者报告的术后胃肠道恢复结果测量(PRO-diGI)的发展。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-03-28 DOI: 10.1093/bjs/znaf055
Matthew J Lee,Daniel M Baker,Debby Hawkins,Sue Blackwell,Robert Arnott,Deena Harji,Gabrielle Thorpe,Stephen J Chapman,Georgina L Jones,
BACKGROUNDAfter major abdominal surgery, patients may experience significant gastrointestinal dysfunction, including postoperative ileus. Many clinical tools are used to measure this dysfunction, but there is no patient-reported outcome measure (PROM) specific to this group. The aim of this study was to develop a new PROM for this common condition.METHODSA four-stage approach was undertaken. Stage 1 used semi-structured interviews with 29 patients to explore experiences of gastrointestinal recovery and develop a draft questionnaire. Stage 2 solicited feedback from 18 patients and 15 clinical experts on the face validity of the proposed tool using the Questionnaire on Questionnaires (QQ-10). Stage 3 recruited 297 patients to complete the questionnaire. Principal component analysis reduced the items and identified the domain structure. Test-retest reliability and a pilot assessment of responsiveness were assessed in stage 4 in a sample of 100 patients and in a sample of 68 patients respectively.RESULTSThe interviews generated 26 subthemes across gastrointestinal recovery and general well-being. An initial questionnaire containing 44 items was developed. The QQ-10 demonstrated high value and low burden, supporting face validity. Tests to reduce the items and identify the domain structure resulted in a 15-item questionnaire across four domains (nausea, eating, well-being, and bowels). Test-retest reliability showed intraclass correlation coefficient values ≥0.7 for all domains. Pilot responsiveness was demonstrated through differences in pre- and post-surgical scores.CONCLUSIONPRO-diGI is a PROM for gastrointestinal dysfunction after major abdominal surgery that shows good psychometric properties and demonstrates face validity, reliability, and responsiveness. This now needs external validation to facilitate broader implementation.
背景腹部大手术后,患者可能会出现严重的胃肠道功能障碍,包括术后回肠梗阻。许多临床工具都用于测量这种功能障碍,但没有专门针对这类患者的患者报告结果测量指标(PROM)。本研究旨在为这种常见疾病开发一种新的 PROM。第一阶段对 29 名患者进行了半结构式访谈,以了解他们在胃肠道恢复方面的经验,并制定了一份问卷草案。第 2 阶段使用问卷调查表 (QQ-10),征求 18 名患者和 15 名临床专家对拟议工具表面效度的反馈意见。第 3 阶段招募了 297 名患者填写问卷。主成分分析减少了项目并确定了领域结构。第 4 阶段分别对 100 名患者样本和 68 名患者样本进行了重测可靠性和响应性试点评估。最初的问卷包含 44 个项目。QQ-10 显示了高价值和低负担,支持表面效度。为减少项目和确定领域结构而进行的测试产生了一份包含 15 个项目的问卷,横跨四个领域(恶心、饮食、幸福感和肠道)。测试-再测可靠性显示,所有领域的类内相关系数均≥0.7。结论PRO-diGI是一款针对腹部大手术后胃肠功能紊乱的PROM,具有良好的心理测量学特性,并显示出面效度、可靠性和响应性。现在需要外部验证,以促进更广泛的实施。
{"title":"Development of a patient-reported outcome measure for gastrointestinal recovery after surgery (PRO-diGI).","authors":"Matthew J Lee,Daniel M Baker,Debby Hawkins,Sue Blackwell,Robert Arnott,Deena Harji,Gabrielle Thorpe,Stephen J Chapman,Georgina L Jones,","doi":"10.1093/bjs/znaf055","DOIUrl":"https://doi.org/10.1093/bjs/znaf055","url":null,"abstract":"BACKGROUNDAfter major abdominal surgery, patients may experience significant gastrointestinal dysfunction, including postoperative ileus. Many clinical tools are used to measure this dysfunction, but there is no patient-reported outcome measure (PROM) specific to this group. The aim of this study was to develop a new PROM for this common condition.METHODSA four-stage approach was undertaken. Stage 1 used semi-structured interviews with 29 patients to explore experiences of gastrointestinal recovery and develop a draft questionnaire. Stage 2 solicited feedback from 18 patients and 15 clinical experts on the face validity of the proposed tool using the Questionnaire on Questionnaires (QQ-10). Stage 3 recruited 297 patients to complete the questionnaire. Principal component analysis reduced the items and identified the domain structure. Test-retest reliability and a pilot assessment of responsiveness were assessed in stage 4 in a sample of 100 patients and in a sample of 68 patients respectively.RESULTSThe interviews generated 26 subthemes across gastrointestinal recovery and general well-being. An initial questionnaire containing 44 items was developed. The QQ-10 demonstrated high value and low burden, supporting face validity. Tests to reduce the items and identify the domain structure resulted in a 15-item questionnaire across four domains (nausea, eating, well-being, and bowels). Test-retest reliability showed intraclass correlation coefficient values ≥0.7 for all domains. Pilot responsiveness was demonstrated through differences in pre- and post-surgical scores.CONCLUSIONPRO-diGI is a PROM for gastrointestinal dysfunction after major abdominal surgery that shows good psychometric properties and demonstrates face validity, reliability, and responsiveness. This now needs external validation to facilitate broader implementation.","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"60 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143819369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic intersphincteric resection with en-bloc prostatectomy for rectal cancer invading the prostate. 机器人括约肌间切除术联合整体前列腺切除术治疗侵犯前列腺的直肠癌。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-03-28 DOI: 10.1093/bjs/znaf064
Kenji Kawada,Ryo Iguchi,Hiroya Matsuoka,Yukio Inamura,Mitsuru Yokota,Kazuyuki Kawamoto
{"title":"Robotic intersphincteric resection with en-bloc prostatectomy for rectal cancer invading the prostate.","authors":"Kenji Kawada,Ryo Iguchi,Hiroya Matsuoka,Yukio Inamura,Mitsuru Yokota,Kazuyuki Kawamoto","doi":"10.1093/bjs/znaf064","DOIUrl":"https://doi.org/10.1093/bjs/znaf064","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"101 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143822671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The future of liver surgery-why it should be minimally invasive. 肝脏手术的未来——为什么它应该是微创的。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-03-28 DOI: 10.1093/bjs/znaf053
Ismaël Chaoui,Mathieu D'Hondt
{"title":"The future of liver surgery-why it should be minimally invasive.","authors":"Ismaël Chaoui,Mathieu D'Hondt","doi":"10.1093/bjs/znaf053","DOIUrl":"https://doi.org/10.1093/bjs/znaf053","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"60 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143822568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The future of liver surgery-open access should still be the front runner. 肝脏手术的未来——开放手术仍将是领跑者。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-03-28 DOI: 10.1093/bjs/znaf046
Guido Torzilli
{"title":"The future of liver surgery-open access should still be the front runner.","authors":"Guido Torzilli","doi":"10.1093/bjs/znaf046","DOIUrl":"https://doi.org/10.1093/bjs/znaf046","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"25 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143822569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symmetrization in therapeutic mammoplasty for breast cancer: si non nunc quandro. 对称在乳腺癌乳房成形术治疗中的应用:si nonununquandro。
IF 8.6 1区 医学 Q1 SURGERY Pub Date : 2025-03-28 DOI: 10.1093/bjs/znaf060
Daniel R Leff, Paul T R Thiruchelvam
{"title":"Symmetrization in therapeutic mammoplasty for breast cancer: si non nunc quandro.","authors":"Daniel R Leff, Paul T R Thiruchelvam","doi":"10.1093/bjs/znaf060","DOIUrl":"10.1093/bjs/znaf060","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"112 4","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11962930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143762686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Role of Lugol solution before total thyroidectomy for Graves' disease: randomized clinical trial. 更正:甲状腺全切除术前卢戈溶液对Graves病的作用:随机临床试验。
IF 8.6 1区 医学 Q1 SURGERY Pub Date : 2025-03-28 DOI: 10.1093/bjs/znaf073
{"title":"Correction to: Role of Lugol solution before total thyroidectomy for Graves' disease: randomized clinical trial.","authors":"","doi":"10.1093/bjs/znaf073","DOIUrl":"https://doi.org/10.1093/bjs/znaf073","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"112 4","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143955766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oesophagectomy in the East versus the West: comparison of two national audit databases. 食管切除术在东方与西方:两个国家审计数据库的比较。
IF 8.6 1区 医学 Q1 SURGERY Pub Date : 2025-03-28 DOI: 10.1093/bjs/znaf035
Satoru Matsuda, Pieter van der Sluis, Hiraku Kumamaru, Feike Kingma, Hirofumi Kawakubo, Jelle Ruurda, Masayuki Watanabe, Hiroaki Miyata, Sjoerd Lagarde, Hiroya Takeuchi, Richard van Hillegersberg, Ken Shirabe, Bas P L Wijnhoven, Yuko Kitagawa
{"title":"Oesophagectomy in the East versus the West: comparison of two national audit databases.","authors":"Satoru Matsuda, Pieter van der Sluis, Hiraku Kumamaru, Feike Kingma, Hirofumi Kawakubo, Jelle Ruurda, Masayuki Watanabe, Hiroaki Miyata, Sjoerd Lagarde, Hiroya Takeuchi, Richard van Hillegersberg, Ken Shirabe, Bas P L Wijnhoven, Yuko Kitagawa","doi":"10.1093/bjs/znaf035","DOIUrl":"https://doi.org/10.1093/bjs/znaf035","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"112 4","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12015469/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143959600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre study. 胃癌胃切除术后并发症对临床结果的影响:多中心研究。
IF 8.6 1区 医学 Q1 SURGERY Pub Date : 2025-03-28 DOI: 10.1093/bjs/znaf043
Sander J M van Hootegem, Margrietha van der Linde, Marcel A Schneider, Jeesun Kim, Felix Berlth, Yutaka Sugita, Peter P Grimminger, Gian Luca Baiocchi, Giovanni De Manzoni, Maria Bencivenga, Suzanne Gisbertz, Souya Nunobe, Han-Kwang Yang, Christian A Gutschow, Sjoerd M Lagarde, Hester F Lingsma, Bas P L Wijnhoven

Background: To reduce the clinical and economic burden of complications after gastrectomy for gastric cancer, specific complications should be targeted to effectively allocate healthcare resources for quality improvement and preventive measures. The aim of this study was to assess the impact of complications on clinical outcomes.

Methods: This was a retrospective multicentre study of patients who underwent (sub)total gastrectomy for gastric or junctional adenocarcinoma at 43 centres in 16 countries between 2017 and 2021. Outcomes were escalation of care, reoperation, prolonged hospital stay (greater than the 75th percentile), readmission, and 30-day mortality. Adjusted relative risks and population attributable fractions were estimated for specific complication-outcome pairs. The population attributable fraction represents the percentage reduction in the frequency of an adverse outcome if a complication could be completely prevented in the population.

Results: In total, 7829 patients were included. Postoperative complications occurred in 1884 patients (24.1%). The most frequent complications were pulmonary complications (436 patients (5.6%)), anastomotic leakage (363 patients (4.6%)), and abdominal collection (301 patients (3.8%)). Anastomotic leakage, cardiac complications, and pulmonary complications had the greatest impact on 30-day mortality (population attributable fraction 26.6% (95% c.i. 14.5% to 38.6%), 18.7% (95% c.i. 9.4% to 28.0%), and 15.6% (95% c.i. 12.0% to 30.0%) respectively). Anastomotic leakage and pulmonary complications had the greatest impact on escalation of care (population attributable fraction 26.3% (95% c.i. 20.6% to 32.0%) and 18.4% (95% c.i. 11.7% to 25.2%) respectively), whereas anastomotic leakage and intra-abdominal bleeding had the greatest impact on reoperation (population attributable fraction 31.6% (95% c.i. 26.4% to 36.9%) and 8.5% (95% c.i. 5.5% to 11.5%) respectively). Most of the studied complications contributed to a prolonged hospital stay, whereas the contribution of complications to readmission did not exceed 15.9%. Subgroup analysis showed regional variation in the impact of complications.

Conclusion: Anastomotic leakage had the largest overall negative impact on clinical outcomes after gastrectomy for gastric adenocarcinoma. Reducing the incidence of anastomotic leakage and pulmonary complications would have the most impact on the burden of complications.

背景:为减轻胃癌胃切除术后并发症的临床负担和经济负担,应针对特定并发症,有效配置医疗资源,提高质量,采取预防措施。本研究的目的是评估并发症对临床结果的影响。方法:这是一项回顾性多中心研究,纳入了2017年至2021年间在16个国家的43个中心因胃或结腺癌接受(亚)全胃切除术的患者。结果是护理升级、再手术、住院时间延长(大于75百分位数)、再入院和30天死亡率。对特定并发症-结局对进行调整后的相对危险度和人群归因分数的估计。人群归因分数表示如果在人群中可以完全预防并发症,则不良后果发生频率降低的百分比。结果:共纳入7829例患者。术后并发症1884例(24.1%)。最常见的并发症为肺并发症(436例(5.6%))、吻合口漏(363例(4.6%))和腹腔收集(301例(3.8%))。吻合口漏、心脏并发症和肺部并发症对30天死亡率的影响最大(人群归因比例分别为26.6% (95% ci . 14.5% ~ 38.6%)、18.7% (95% ci . 9.4% ~ 28.0%)和15.6% (95% ci . 12.0% ~ 30.0%)。吻合口漏和肺部并发症对护理升级的影响最大(人口归因比例分别为26.3% (95% c.i. 20.6% ~ 32.0%)和18.4% (95% c.i. 11.7% ~ 25.2%)),而吻合口漏和腹腔内出血对再手术的影响最大(人口归因比例分别为31.6% (95% c.i. 26.4% ~ 36.9%)和8.5% (95% c.i. 5.5% ~ 11.5%))。大多数研究的并发症导致住院时间延长,而并发症对再入院的贡献不超过15.9%。亚组分析显示并发症的影响存在区域差异。结论:吻合口漏对胃腺癌胃切除术后临床预后的总体负面影响最大。减少吻合口漏和肺部并发症的发生率对减轻并发症负担影响最大。
{"title":"Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre study.","authors":"Sander J M van Hootegem, Margrietha van der Linde, Marcel A Schneider, Jeesun Kim, Felix Berlth, Yutaka Sugita, Peter P Grimminger, Gian Luca Baiocchi, Giovanni De Manzoni, Maria Bencivenga, Suzanne Gisbertz, Souya Nunobe, Han-Kwang Yang, Christian A Gutschow, Sjoerd M Lagarde, Hester F Lingsma, Bas P L Wijnhoven","doi":"10.1093/bjs/znaf043","DOIUrl":"10.1093/bjs/znaf043","url":null,"abstract":"<p><strong>Background: </strong>To reduce the clinical and economic burden of complications after gastrectomy for gastric cancer, specific complications should be targeted to effectively allocate healthcare resources for quality improvement and preventive measures. The aim of this study was to assess the impact of complications on clinical outcomes.</p><p><strong>Methods: </strong>This was a retrospective multicentre study of patients who underwent (sub)total gastrectomy for gastric or junctional adenocarcinoma at 43 centres in 16 countries between 2017 and 2021. Outcomes were escalation of care, reoperation, prolonged hospital stay (greater than the 75th percentile), readmission, and 30-day mortality. Adjusted relative risks and population attributable fractions were estimated for specific complication-outcome pairs. The population attributable fraction represents the percentage reduction in the frequency of an adverse outcome if a complication could be completely prevented in the population.</p><p><strong>Results: </strong>In total, 7829 patients were included. Postoperative complications occurred in 1884 patients (24.1%). The most frequent complications were pulmonary complications (436 patients (5.6%)), anastomotic leakage (363 patients (4.6%)), and abdominal collection (301 patients (3.8%)). Anastomotic leakage, cardiac complications, and pulmonary complications had the greatest impact on 30-day mortality (population attributable fraction 26.6% (95% c.i. 14.5% to 38.6%), 18.7% (95% c.i. 9.4% to 28.0%), and 15.6% (95% c.i. 12.0% to 30.0%) respectively). Anastomotic leakage and pulmonary complications had the greatest impact on escalation of care (population attributable fraction 26.3% (95% c.i. 20.6% to 32.0%) and 18.4% (95% c.i. 11.7% to 25.2%) respectively), whereas anastomotic leakage and intra-abdominal bleeding had the greatest impact on reoperation (population attributable fraction 31.6% (95% c.i. 26.4% to 36.9%) and 8.5% (95% c.i. 5.5% to 11.5%) respectively). Most of the studied complications contributed to a prolonged hospital stay, whereas the contribution of complications to readmission did not exceed 15.9%. Subgroup analysis showed regional variation in the impact of complications.</p><p><strong>Conclusion: </strong>Anastomotic leakage had the largest overall negative impact on clinical outcomes after gastrectomy for gastric adenocarcinoma. Reducing the incidence of anastomotic leakage and pulmonary complications would have the most impact on the burden of complications.</p>","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"112 4","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11953074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143741773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FUT2 and FUT3-specific normalization of DUPAN-2 and carbohydrate antigen 19-9 in preoperative therapy for pancreatic cancer: multicentre retrospective study (GEMINI-PC-01). 胰腺癌术前治疗中DUPAN-2和糖类抗原19-9的FUT2和fut3特异性正常化:多中心回顾性研究(GEMINI-PC-01)
IF 8.6 1区 医学 Q1 SURGERY Pub Date : 2025-03-28 DOI: 10.1093/bjs/znaf049
Haruyoshi Tanaka, Ayano Sakai, Masaya Suenaga, Masamichi Hayashi, Tomohisa Otsu, Nobuhiko Nakagawa, Keisuke Kurimoto, Mina Fukasawa, Kazuto Shibuya, Nobuyuki Watanabe, Masaki Sunagawa, Junpei Yamaguchi, Takashi Mizuno, Toshio Kokuryo, Hideki Takami, Tomoki Ebata, Tsutomu Fujii, Yasuhiro Kodera
{"title":"FUT2 and FUT3-specific normalization of DUPAN-2 and carbohydrate antigen 19-9 in preoperative therapy for pancreatic cancer: multicentre retrospective study (GEMINI-PC-01).","authors":"Haruyoshi Tanaka, Ayano Sakai, Masaya Suenaga, Masamichi Hayashi, Tomohisa Otsu, Nobuhiko Nakagawa, Keisuke Kurimoto, Mina Fukasawa, Kazuto Shibuya, Nobuyuki Watanabe, Masaki Sunagawa, Junpei Yamaguchi, Takashi Mizuno, Toshio Kokuryo, Hideki Takami, Tomoki Ebata, Tsutomu Fujii, Yasuhiro Kodera","doi":"10.1093/bjs/znaf049","DOIUrl":"https://doi.org/10.1093/bjs/znaf049","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"112 4","pages":""},"PeriodicalIF":8.6,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12037208/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143955957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
British Journal of Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1